Journal of Clinical Endocrinology & Metabolism, Vol 45, 1187-1193, Copyright © 1977 by Endocrine Society

ARTICLES

The placental transfer of propylthiouracil, methimazole and carbimazole

B Marchant, BE Brownlie, DM Hart, PW Horton and WD Alexander

The placental transfer of 35S-labelled methimazole (MMI), carbimazole and propylthiouracil (PTU) has been examined in the rat in late pregnancy and in patients undergoing therapeutic abortion. Although rapid equilibrium of fetal and maternal serum radioactivity (FS:MS ratio 1:1) occurred after iv administration of 35S-carbimazole or 35S- MMI in rats, a persistent fetal to maternal ratio of less than one was observed after 35S-PTU administration. Results from human studies after a single oral dose indicate that, as in the rat, the placenta appeared to be more permeable to 35S-MMI than to 35S-PTU as shown by the marked difference in fetal serum:maternal serum ratios and amounts accumulated in the fetus. Localization of radioactivity in the human fetal thyroid was also observed after administration of 35S-labelled MMI, carbimazole or PTU.

This article has been cited by other articles:

				M. A. Taylor, J. Swant, J. J. Wagner, J. W. Fisher, and D. C. Ferguson Lower Thyroid Compensatory Reserve of Rat Pups after Maternal Hypothyroidism: Correlation of Thyroid, Hepatic, and Cerebrocortical Biomarkers with Hippocampal Neurophysiology Endocrinology, July 1, 2008; 149(7): 3521 - 3530. [Abstract] [Full Text] [PDF]

				Subsection Reports J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47. [Full Text] [PDF]

				M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47. [Abstract] [Full Text] [PDF]

				J. M Chattaway and T. B Klepser Propylthiouracil Versus Methimazole in Treatment of Graves' Disease During Pregnancy Ann. Pharmacother., June 1, 2007; 41(6): 1018 - 1022. [Abstract] [Full Text] [PDF]

				D. D Streetman and U. Khanderia Diagnosis and Treatment of Graves Disease Ann. Pharmacother., July 1, 2003; 37(7): 1100 - 1109. [Abstract] [Full Text] [PDF]

				S. J. Mandel and D. S. Cooper The Use of Antithyroid Drugs in Pregnancy and Lactation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2354 - 2359. [Full Text] [PDF]

				M. Knipper, C. Zinn, H. Maier, M. Praetorius, K. Rohbock, I. Kopschall, and U. Zimmermann Thyroid Hormone Deficiency Before the Onset of Hearing Causes Irreversible Damage to Peripheral and Central Auditory Systems J Neurophysiol, May 1, 2000; 83(5): 3101 - 3112. [Abstract] [Full Text] [PDF]

				M. Alvarez-Dolado, M. Ruiz, J. A. Del Rio, S. Alcantara, F. Burgaya, M. Sheldon, K. Nakajima, J. Bernal, B. W. Howell, T. Curran, et al. Thyroid Hormone Regulates reelin and dab1 Expression During Brain Development J. Neurosci., August 15, 1999; 19(16): 6979 - 6993. [Abstract] [Full Text] [PDF]

				M J O'Doherty, P R McElhatton, and S H L Thomas Treating thyrotoxicosis in pregnant or potentially pregnant women BMJ, January 2, 1999; 318(7175): 5 - 6. [Full Text]

				N. Momotani, J. Yoshimura Noh, N. Ishikawa, and K. Ito Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Graves' Hyperthyroidism J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3633 - 3636. [Abstract] [Full Text] [PDF]

				R. H. Mortimer, G. R. Cannell, R. S. Addison, L. P. Johnson, M. S. Roberts, and I. Bernus Methimazole and Propylthiouracil Equally Cross the Perfused Human Term Placental Lobule J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3099 - 3102. [Abstract] [Full Text] [PDF]

				The practical management of thyroid disease in pregnancy DTB, October 1, 1995; 33(10): 75 - 77. [Abstract] [Full Text] [PDF]